- The author expresses frustration that many promising treatments and strategies for COVID-19 are not being pursued seriously despite some evidence.
- The medical field is conservative, partly due to past scandals like falsified data on beta-blockers that cost many lives.
- Trials on remdesivir and hydroxychloroquine were rushed but ultimately failed, yet some drugs like dexamethasone proved effective for severely ill patients.
- Vitamin D deficiency is strongly associated with worse COVID-19 outcomes, but authorities are not actively promoting supplementation due to lack of 'proof.'
- Ivermectin has shown positive results in 22 studies, including 9 randomized controlled trials, but is ignored in treatment guidelines partly due to an early fraudulent preprint.
- Antigenic tests are fast, cheap, and can detect infectious individuals with high sensitivity, yet the medical field often dismisses them as inferior to PCR tests instead of considering their practical advantages.
- Other promising treatments like bromhexine and nebulised interferon beta-1a have theoretical support and some trial success but are not being adequately studied.
- The author calls for more institutional trials like the UK RECOVERY trial to gather evidence for these candidates.